FDA panel recommends Moderna COVID vaccine as option for kids 6 and up
On Wednesday, the same FDA advisory committee will discuss allowing COVID vaccines from Moderna and Pfizer for younger children.
Stay updated with breaking news from Precision Vaccines Program. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
On Wednesday, the same FDA advisory committee will discuss allowing COVID vaccines from Moderna and Pfizer for younger children.
To answer that question, expanded testing is needed that can determine levels of T immune cells
Researchers at the Precision Vaccines Program at Boston Children’s Hospital recently partnered with the Expanded Program on Immunization Consortium, an international team studying early life immunization, to collect and comprehensively profile blood samples from newborns immunized with the century-old Bacille Calmette-Guérin (BCG) vaccine, using a powerful “big data” approach.
The century-old Bacille Calmette-Guérin (BCG) vaccine against tuberculosis is one of the world's oldest and most widely used vaccines, used to immunize 100 million newborns every year. Given in countries with endemic TB, it has surprisingly been found to protect newborns and young infants against multiple bacterial and viral infections unrelated to TB. There's even some evidence that it can reduce severity of COVID-19.
This article is part of Harvard Medical School’s continuing coverage of COVID-19.